GROSSMAN JERROLD B purchased 2.6% of their position (12.50K shares) of ADMA BIOLOGICS, INC. on the open market
Open‑market purchase worth $100.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/12/2026ACC: 0001140361-26-020855
+12.50K
Net shares
Net buyer
$100.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.50K
Price / share
$8.01
Trade value
$100.13K
% of position
2.6%
5/11/2026
488.88K→501.38K
Total
Net shares
+12.50K
Net value
$100.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | P · Purchase | +12.50K | $8.01 | $100.13K | 2.6% | 488.88K | 501.38K |
| Total | +12.50K | $100.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned175.00
Common Stock
IndirectShares owned22.86K
Common Stock
IndirectShares owned38.29K
Common Stock
IndirectShares owned31.38K
Total
92.71K indirect92.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 175.00 | Indirect |
| Common Stock | 22.86K | Indirect |
| Common Stock | 38.29K | Indirect |
| Common Stock | 31.38K | Indirect |
| Total | 92.71K | 92.71K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported